Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IGMS | Common Stock | Award | $4.53K | +353 | +1.05% | $12.84 | 34.1K | Nov 15, 2022 | Direct | F1 |
transaction | IGMS | Common Stock | Sale | -$12.8K | -600 | -1.76% | $21.38 | 33.5K | Nov 23, 2022 | Direct | F2, F3 |
transaction | IGMS | Common Stock | Sale | -$6.09K | -277 | -0.83% | $21.99 | 33.2K | Nov 23, 2022 | Direct | F2, F4 |
Id | Content |
---|---|
F1 | The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
F2 | These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |
F3 | This transaction was executed in multiple trades at prices ranging from $20.74 to $21.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F4 | This transaction was executed in multiple trades at prices ranging from $21.74 to $22.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |